HOOK HOOKIPA Pharma Inc.

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Latest News

1. 06 January 2020 HOOKIPA's Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

   NEW YORK and VIENNA, Austria, Jan. 06, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

2. 30 December 2019 HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

   NEW YORK and VIENNA, Austria, Dec. 30, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

3. 25 November 2019 HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference

   NEW YORK and VIENNA, Austria, Nov. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

4. 12 November 2019 HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

   NEW YORK and VIENNA, Austria, Nov. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

5. 04 November 2019 HOOKIPA Pharma To Report Third Quarter 2019 Financial Results on November 12, 2019

   NEW YORK and VIENNA, Austria, Nov. 04, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

6. 31 October 2019 HOOKIPA Pharma to Present at Upcoming Conferences in November

   NEW YORK and VIENNA, Austria, Oct. 31, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on

7. 25 September 2019 HOOKIPA Announces Key Hires to its Executive Team

   Christine D. Baker has joined as Chief Business Officer Roman Necina, PhD, will join as Chief Technology Officer  NEW YORK and VIENNA, Austria, Sept. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK,

8. 19 September 2019 HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris

   NEW YORK and VIENNA, Austria, Sept. 19, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on